Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Sunday, January 25, 2009

1999 paper: Differentiation of mouth versus gut as site of origin of odoriferous breath gases after garlic ingestion

1999 paper :

Differentiation of mouth versus gut as site of origin of odoriferous breath gases after garlic ingestion

F. Suarez, J. Springfield, J. Furne, and M. Levitt
MALODOROUS BREATH (halitosis) is a common problem that has received extensive study (2-5, 10-12, 17-19). Virtually all of these studies have worked on the assumption that the malodorous compounds originate in the mouth (2-5, 10, 11, 17-19). However, there is abundant evidence that gases produced by the microflora of the gut, such as hydrogen and methane, are efficiently absorbed into the portal blood flow and then excreted in expired air (7). The extent to which odoriferous breath gases are derived from the mouth versus the gut has not been rigorously investigated. This differentiation is of importance because cleansing of the oral cavity would not be expected to appreciably reduce the breath concentration of gases derived from the gut.
Many people who feel that halitosis is their problem in our community are unsure if it's oral based or metabolic. Traditionally, metabolic halitosis has not been considered. Recently, because of trimethylaminuria, the few papers on that subject include the notion of trimethylaminuria halitosis.

In this paper, from 1999, they consider it the first looking into the concept of metabolic halitosis by provoking it with the consumption of garlic, which is commonly known to cause smells. For anyone who hasn't thought of the principle of metabolic odors before, another obvious example would be drinkers having alcohol breath and perhaps hours later having alcohol body odor too. This is basically consumption of so much alcohol that it is circulating freely in the blood. Another example would be those who get 'curry body odor' after eating a curry.

The results of this study demonstrate that halitosis may be of oral and/or gut origin. A rational approach to the treatment of this common problem presumably should begin with the identification of the malodorous gas and its site of origin. The simple techniques utilized in the present study make it possible to differentiate between a mouth versus gut origin. In the paper, they investigate where the garlic smells are coming from. They test the mouth breath, and the alveolar breath (breath from the lungs), and urine. Mostly, the compounds that turn up in their results are detected from the mouth breath largely, apart from allylmethyldisulfide (AMS), which turns up later in the urine. Through work they have done on rats, they have discovered that this isn't easily metabolized by rats or humans. They conclude that the other odorous compounds found were quickly metabolized when absorbed, and so didn't show in alveolar breath or urine in significant size. They used 'normal healthy' volunteers for testing. It may have been very different if they used metabolic body odor patients.

Currently, any expert interested in trimethylaminuria will likely only test for TMAU. It would be interesting to see how someone with a weakened FMO system coped with these Volatile Organic Compounds (VOCs) found in the garlic test, since most of them are likely FMO substrates. It seems ironic that those who are burdened with metabolic body odor are only offered the TMAU test whereas in the other tests done on pubmed they seem to test for all VOCs to see what turns up. Perhaps someday the metabolic body odor and halitosis test will be a blank check of VOCs, rather than just one compound.

The researchers in this paper have been involved in much research to do with compounds and concepts that are likely of interest to metabolic body odor and halitosis sufferers


Post a Comment